OpenVSafe by OpenVAERS
Search V-safe

6YW-22670-46144

3 vaccinations 3 coded responses 31 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
292 / SC
Registered
2021-01-01
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  9. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-21
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-22
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-10-05
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  20. 2021-10-05
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · Headache
    Adult check-in
  22. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oedema peripheral — Feeling: Good · Site: Pain
    Free text: Axillary swelling
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Axillary pain — Feeling: Good · Site: Pain
    Free text: Axillary Pain
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-10-12
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-19
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-26
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-11-04
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-11-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-01-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-04-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-10-06
    Survey response — 12 months, dose 3
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Chronic cough. Increased reactive airway.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-10-06
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-10-06
    Call successful
    Not applicable - Accidental Reporting

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Pfizer-BioNTech
22021-01-21Pfizer-BioNTech
32021-10-05Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2022-10-06 Successful
2022-10-06
 Not applicable - Accidental Reporting

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-07

Systemic reaction (other): Axillary swelling

2021-10-08

Systemic reaction (other): Axillary Pain

Release 12 — 12 months, dose 3

2022-10-06

Symptoms: Chronic cough. Increased reactive airway.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated · · ✓
SDPre-existing disease · · ✓
SROAxillary pain · · ✓
SROOedema peripheral · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…